PD-1 AND ANTI-PD-1 ANTIBODIES DURING INFECTIONS OF THE CENTRAL NERVOUS SYSTEM
S. Stuard1 and M. Rosati2* 1 Global Medical Office, FMC Germany, Bad Homburg, Germany; 2 Department of Obstetrics and Gynecology,...
S. Stuard1 and M. Rosati2* 1 Global Medical Office, FMC Germany, Bad Homburg, Germany; 2 Department of Obstetrics and Gynecology,...
D. Kempuraj* Research Laboratory at the Institute for Neuroimmune Medicine, Nova Southeastern University, Florida, USA. *Correspondence to: Duraisamy Kempuraj, Research...
Letter to the Editor J. Vecchiet* Department of Medicine and Ageing Sciences,“G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy. *Correspondence to:...
Letter to the Editor F. Agostini* Stem Cell Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. *Correspondence...
C. D’Aurizio1 and F. Danzo2* 1 Department of Neurorehabilitation, Popoli Hospital, Popoli, Italy; 2 Division of Respiratory Diseases, “L. Sacco”...
F. Pandolfi * Allergy and Clinical Immunology, Fondazione Policlinico Universitario A, Gemelli IRCCS, Catholic University, Rome, Italy. *Correspondence to: Franco...
Al. Caraffa * School of Pharmacy, University of Camerino, Camerino, Italy. *Correspondence to: Alessandro Caraffa, MD, School of Pharmacy, University...
D. Lauritano * Department of Medicine and Surgery, Centre of Neuroscience of Milan, University of Milano-Bicocca, Milan, Italy. *Correspondence to:...
Please submit your papers to:
ejnd@biolife-publisher.it
More
Submit your article to:
e-mail: ejnd@biolife-publisher.it.
Editorial correspondence:
Biolife Publisher
viale Unità d’Italia 73,
66100, Chieti, Italy.
Tel./Fax +39 0871 574136
e-mail: ejnd@biolife-publisher.it
Commercial correspondence
including advertising, and requests for back numbers and reprints should be sent electronically to
e-mail: info@biolife-publisher.it
ISSN Online 3103-7364
ISSN Print 2279-5855